[ad_1]
Thousands of heart patients have been warned, urging them to check their medications as they fear to contain carcinogenic chemicals.
The UK's Health and Medicines Regulatory Agency (MHRA) has warned of a drug that may contain carcinogens and has called on pharmacies to recover all "ibresartan" drugs, the third such demand since beginning of the year.
The Regulatory Agency for Drugs and Health Care Products said that drugs should not be stopped without consulting a doctor, as this could be life-threatening.
The agency pointed out that there was no evidence so far that the drug actually caused harm to patients.
"Patient safety is our top priority, and we will take all necessary steps to protect public health," said Dr. Sam Atkinson, Director of the Ministry's Department of Investigation, Standards and Standards. Human Rights.
"Today's reminder reminds us of the need to recover Irbesartan-based drugs and we continue to investigate the possibility of contamination with drugs containing receptor antagonists." Antigens or known as sartan, a class of drugs used to treat hypertension, heart attacks and heart failure. "
These warnings follow earlier reports that led to recall of Dexcel and Actavis heart medication in July, from Mylan and Teva in November, containing the same chemical.
The drugs were recovered throughout Europe as a result of an urgent investigation into carotene and falcartin-based medicines produced in China.
Experts fear that the drugs that have been called contain "N-nitrosodimethylamine" and "N-nitrosodiethylamine", which can be carcinogenic and present in drugs as a result of changes in manufacturing processes.
The European Medicines Agency and other organizations of the EU are working together to study the extent of this problem and its potential impact on patients.
Source: Russia today
[ad_2]
Source link
